Anti-influenza drugs

Development of new drugs against influenza has been of great interest. Number of drugs show Anti-influenza properties, but may have altered effects for the use in clinic. These drugs target viral components and some target the host cell elements which help in the viral cycle, but related side effects are the disadvantages. As for now, four antiviral drugs have been discovered against influenza; zanamivir and oseltamivir which inhibit neuraminidase which act in both Influenza A and Influenza B, while rimantadine and amantadine block M2 passage of influenza A.

 

  • Clinical trials
  • Influenza and pneumonia
  • Influenza immunization
  • Ethical preparedness

Related Conference of Anti-influenza drugs

November 19-19, 2021

11th European Epidemiology and Public Health Congress

Paris, France
December 01-01, 2021

4th International Conference on Tropical and Infectious Diseases

Amsterdam, Netherlands
February 07-08, 2022

9th International Congress on Infectious Diseases

Aberdeen, UK
March 09-10, 2022

VIROLOGY CONFERENCE-INFE-2022

Geneva, Switzerland
April 25-26, 2022

4th World Congress on Advancements in Tuberculosis and Lung Diseases

Singapore City, Singapore
June 24-25, 2022

14th Euro-Global Conference on Infectious Diseases

Berlin, Aland Islands

Anti-influenza drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in